Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Biological Response Modifiers Advisory Committee

Executive Summary

Biological Response Modifiers Advisory Committee: Will discuss CellPro's PMA 94-001 for its Ceprate SC device for selection of CD34+ progenitor/stem cells on Feb. 28, followed by an update on stem cell policy. On Feb. 29, the committee will consider issues in early clinical trial development of in utero stem cell transplantation and the draft document "Addendum on gene therapy to the 1991 points-to-consider on human somatic cell and gene therapy." The meeting will begin at 8:30 a.m. at the Bethesda, Md. Holiday Inn...
UsernamePublicRestriction

Register

PS027583

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel